BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12670333)

  • 21. Abnormalities of primitive myeloid progenitor cells expressing granulocyte colony-stimulating factor receptor in patients with severe congenital neutropenia.
    Nakamura K; Kobayashi M; Konishi N; Kawaguchi H; Miyagawa S; Sato T; Toyoda H; Komada Y; Kojima S; Katoh O; Ueda K
    Blood; 2000 Dec; 96(13):4366-9. PubMed ID: 11110716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
    Freedman MH; Alter BP
    Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired neutrophil maturation in truncated murine G-CSF receptor-transgenic mice.
    Mitsui T; Watanabe S; Taniguchi Y; Hanada S; Ebihara Y; Sato T; Heike T; Mitsuyama M; Nakahata T; Tsuji K
    Blood; 2003 Apr; 101(8):2990-5. PubMed ID: 12672695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders.
    Tsuruta T; Tani K; Shimane M; Ozawa K; Takahashi S; Tsuchimoto D; Takahashi K; Nagata S; Sato N; Asano S
    Br J Haematol; 1996 Jan; 92(1):9-22. PubMed ID: 8562417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor.
    Fukunaga R; Ishizaka-Ikeda E; Nagata S
    Cell; 1993 Sep; 74(6):1079-87. PubMed ID: 7691413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.
    Hunter MG; Druhan LJ; Massullo PR; Avalos BR
    Am J Hematol; 2003 Nov; 74(3):149-55. PubMed ID: 14587040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells.
    Lanza F; Castagnari B; Rigolin G; Moretti S; Latorraca A; Ferrari L; Bardi A; Castoldi G
    Leukemia; 1997 Oct; 11(10):1700-10. PubMed ID: 9324292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes.
    Morikawa K; Morikawa S; Nakamura M; Miyawaki T
    Br J Haematol; 2002 Jul; 118(1):296-304. PubMed ID: 12100165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival.
    Hunter MG; Avalos BR
    Blood; 2000 Mar; 95(6):2132-7. PubMed ID: 10706885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia.
    Druhan LJ; Ai J; Massullo P; Kindwall-Keller T; Ranalli MA; Avalos BR
    Blood; 2005 Jan; 105(2):584-91. PubMed ID: 15353486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse.
    Ehlers S; Herbst C; Zimmermann M; Scharn N; Germeshausen M; von Neuhoff N; Zwaan CM; Reinhardt K; Hollink IH; Klusmann JH; Lehrnbecher T; Roettgers S; Stary J; Dworzak M; Welte K; Creutzig U; Reinhardt D
    J Clin Oncol; 2010 May; 28(15):2591-7. PubMed ID: 20406937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
    Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
    N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-155 is associated with the leukemogenic potential of the class IV granulocyte colony-stimulating factor receptor in CD34⁺ progenitor cells.
    Zhang H; Goudeva L; Immenschuh S; Schambach A; Skokowa J; Eiz-Vesper B; Blasczyk R; Figueiredo C
    Mol Med; 2015 Apr; 20(1):736-46. PubMed ID: 25730818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin-2 receptor alpha chain.
    Shikami M; Miwa H; Nishii K; Takahashi T; Shiku H; Tsutani H; Oka K; Hamaguchi H; Kyo T; Tanaka K; Kamada N; Kita K
    Br J Haematol; 1999 Jun; 105(3):711-9. PubMed ID: 10354136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocyte-colony stimulating factor-induced proliferation of primary adult T-cell leukaemia cells.
    Matsushita K; Arima N; Ohtsubo H; Fujiwara H; Hidaka S; Kukita T; Suruga Y; Fukumori J; Matsumoto T; Kanzaki A; Yawata Y; Tanaka H
    Br J Haematol; 1997 Mar; 96(4):715-23. PubMed ID: 9074411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression.
    Davis RE; Greenberg PL
    Leuk Res; 1998 Sep; 22(9):767-77. PubMed ID: 9716007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.